Suven Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 25, 2025, titled "Press Release".
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The company has informed the stock exchange that Suven Pharmaceuticals Limited has issued a press release dated April 25, 2025. No specific details, financial figures, or subject matter from the press release are included in this filing — only the reference and date are provided. Suven Pharmaceuticals appears to be referenced as a related or predecessor entity to Cohance Lifesciences, suggesting a corporate restructuring or rebranding relationship.
Without the actual contents of the press release, the financial or operational impact on shareholders cannot be assessed from this filing alone. Investors should look for the full press release to understand any material developments.